Catherine V. de Whalley

Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages

Catherine V. de Whalley, Sara M. Rankin, J.R.S. Hoult et al. · Biochemical Pharmacology · 1990 · 613 citations

Inflammation, Oxysterol, Biochemistry +8

<i>α</i>-tocopherol consumption during low-density-lipoprotein oxidation

W. Jessup, Sara M. Rankin, Catherine V. de Whalley et al. · Biochemical Journal · 1990 · 308 citations · Full text

Oxysterol, Low-density-lipoprotein Oxidation, Biochemistry +10

The modification of low density lipoprotein by the flavonoids myricetin and gossypetin

Sara M. Rankin, Catherine V. de Whalley, J.R.S. Hoult et al. · Biochemical Pharmacology · 1993 · 58 citations

Low Density Lipoprotein, Biochemistry, Medicine +8

The Role of Oxidative Modification and Antioxidants in LDL Metabolism and Atherosclerosis

Wendy Jessup, Roger T. Dean, Catherine V. de Whalley et al. · Advances in experimental medicine and biology · 1990 · 35 citations

Metabolic Syndrome, Oxysterol, Biochemistry +13

Influence of the cytocidal macrophage phenotype on the degradation of acetylated low density lipoproteins: Dual regulation of scavenger receptor activity and of intracellular degradation of endocytosed ligand

Catherine V. de Whalley, David W. H. Riches · Experimental Cell Research · 1991 · 15 citations

Inflammation, Oxysterol, Biochemistry +11